论文部分内容阅读
目的:探讨联用缬沙坦和氨氯地平对原发性高血压患者进行治疗的临床效果。方法:对近期我院收治的60例原发性高血压患者的临床资料进行回顾性研究。我院将这60例患者随机分为联合组和对照组,每组各有30例患者。为对照组患者使用缬沙坦进行治疗,为联合组患者联用缬沙坦和氨氯地平进行治疗。治疗结束后,比较两组患者进行治疗的效果及不良反应的发生情况。结果:进行治疗后,联合组患者进行治疗的总有效率及其血压水平均明显好于对照组患者,二者相比差异具有统计学意义(P<0.05)。在进行治疗期间,两组患者均未出现明显的不良反应。结论:联用缬沙坦和氨氯地平对原发性高血压患者进行治疗的效果显著,可有效地改善其血压水平。此治疗方法值得在临床上推广应用。
Objective: To investigate the clinical effect of combined valsartan and amlodipine on patients with essential hypertension. Methods: The clinical data of 60 patients with primary hypertension treated in our hospital were retrospectively studied. Our hospital will be 60 patients were randomly divided into combined group and control group, each group has 30 patients. The patients in the control group were treated with valsartan, and the patients in the combination group were treated with valsartan and amlodipine. After treatment, the effects of treatment and adverse reactions in the two groups were compared. Results: After the treatment, the total effective rate and the blood pressure of the patients in the combined group were significantly better than those in the control group. The difference was statistically significant (P <0.05). During the treatment, no significant adverse reactions occurred in both groups. Conclusion: The combination of valsartan and amlodipine can significantly improve the blood pressure of patients with essential hypertension. This treatment is worth promoting in clinical application.